Reena Philip
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- PARP inhibition in cancer therapy
- Lung Cancer Research Studies
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Treatments and Studies 2
-
- Cancer Genomics and Diagnostics 8
- Co-authors
- Richard Pazdur (7 shared papers)Julia A. Beaver (7 shared papers)Lisa Rodríguez (3 shared papers)Soma Ghosh (6 shared papers)Martha Donoghue (2 shared papers)Lola A. Fashoyin‐Aje (1 shared paper)Pamela Gallagher (2 shared papers)Steven J. Lemery (1 shared paper)
- Journals
- Clinical Cancer Research (4 papers)The Oncologist (4 papers)Expert Review of Molecular Diagnostics (2 papers)Clinical Chemistry (2 papers)Plant Science (2 papers)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Reena Philip
23 papers receiving 1.1k citations
Reena Philip's Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 583
- Cancer Research 293
- Pulmonary and Respiratory Medicine 302
- Pathology and Forensic Medicine 141
- Biotechnology 63
Countries citing papers authored by Reena Philip
This map shows the geographic impact of Reena Philip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reena Philip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reena Philip more than expected).
Fields of papers citing papers by Reena Philip
This network shows the impact of papers produced by Reena Philip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reena Philip. The network helps show where Reena Philip may publish in the future.
Co-authors
The 25 scholars most cited alongside Reena Philip, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors Hit paper breakdown → | 2021 | 330 |
| 2 | 2018 | 166 | |
| 3 | 2020 | 127 | |
| 4 | 2018 | 98 | |
| 5 | 2017 | 49 | |
| 6 | 2001 | 45 | |
| 7 | 2009 | 37 | |
| 8 | 2023 | 36 | |
| 9 | 2023 | 33 | |
| 10 | 2012 | 31 | |
| 11 | 2016 | 26 | |
| 12 | 2011 | 23 | |
| 13 | 1999 | 20 | |
| 14 | 2024 | 18 | |
| 15 | 1998 | 18 | |
| 16 | 2015 | 15 | |
| 17 | 2020 | 12 | |
| 18 | 2001 | 10 | |
| 19 | 2020 | 7 | |
| 20 | 2005 | 5 |
About Reena Philip
Reena Philip is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Plant Science, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Statistical Methods in Clinical Trials (5 papers), Lung Cancer Treatments and Mutations (5 papers), Biosimilars and Bioanalytical Methods (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Transgenic Plants and Applications (2 papers) and Soybean genetics and cultivation (1 paper). The work is most often cited by research in Oncology (583 citations), Cancer Research (293 citations), Pulmonary and Respiratory Medicine (302 citations), Pathology and Forensic Medicine (141 citations) and Biotechnology (63 citations). Reena Philip has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Richard Pazdur, Julia A. Beaver, Lisa Rodríguez, Soma Ghosh, Martha Donoghue, Lola A. Fashoyin‐Aje, Pamela Gallagher, Steven J. Lemery, Leigh Marcus and Mengdie Yuan. Their work appears in journals such as Clinical Cancer Research, The Oncologist, Expert Review of Molecular Diagnostics, Clinical Chemistry and Plant Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.